Press Releases
Aptar Pharma and Propeller Health Partner to Develop Digital Medicine Platform Across Therapeutic Areas
Aptar Pharma, a leading provider of innovative drug delivery systems, and Propeller Health, a leading digital therapeutics company, announced plans to collaborate on the launch of a comprehensive platform to develop digital medicines for multiple therapeutic areas and diseases....
Press Releases
More Global Recognition for CRF Health’s eSource Solutionswith European Award Win
CRF Health, a leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, announced that the company has been recognized as2018 New Entrant of the Year in Romania’s PIN Awards. Launched...
Press Releases
CPhI report predicts new finished product manufacturing hub in the Middle East
A new report by CPhI forecasts sizable changes ahead for the pharma markets in the Middle East and Africa over the next few years. It highlights recent regulatory changes, coupled with increased geopolitical stability and rising...
Press Releases
Pfizer’s Biosimilar RETACRIT® (epoetin alfa-epbx) Approved by U.S. FDA
Pfizer Inc. announced the United States FDA approved RETACRIT® (epoetin alfa-epbx), a biosimilar to Epogen® and Procrit® (epoetin alfa)1, for all indications of the reference product. RETACRIT is now the first and only biosimilar erythropoiesis-stimulating agent (ESA) to be...
Press Releases
Recipharm invests in Brexit preparations
Recipharm, the contract development and manufacturing organisation (CDMO), has established a dedicated taskforce to manage the potential impact of Brexit on its organisation. With less than a year until the UK exits the European Union (EU),...
Press Releases
Aptar Pharma to Unveil Inhalation Drug Delivery Solutions at CPhI China 2018
Aptar Pharma, a leading drug delivery systems provider, is pleased to be exhibiting once again at CPhI China 2018, taking place from June 20-22 at the Shanghai New International Exhibition Center, Shanghai, China. At Booth No....
Press Releases
Lonza Further Strengthens Hepatocytes Portfolio with Addition of Hepatic Non-Parenchymal Cells
Lonza announced the addition of hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio. These hepatic non-parenchymal cells provide scientists with the building blocks to create more physiologically relevant in vitro...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read